Samsung joins other developers by introducing an ECG-enabled smartwatch, but single-lead ECG prediction of atrial fibrillation (AFib) events is still an industrywide challenge

August 07, 2019 | Case Study

A report from Wareable claims that Samsung will feature ECG-sensing capability in its upcoming smartwatch, the Galaxy Watch Active 2, in the first half of 2020. If this claim is accurate, Samsung now joins Apple, Withings, and Verily as the next tech developer that plans to enter the cardiac care space using smartwatches in predicting atrial fibrillation (AFib).